Thomas Krenitsky, CEO Krenitsky Pharmaceuticals, Former VP Research 1989-1995

Dr Krenitsky joined BW in 1966 as a biochemist, working with Elion and Hitchings. In 1989 he became Vice-President of Research and left the company in 1995.

Topics discussed include:

*Bill Creasy, his working relationship with staff, management style, and departure from the company

* Empirin

* Gertrude Elion and George Hitchings, their approach to research and staff, obtaining internal and external funding, standing within the scientific community, Noble Prize

* Sloan Kettering Institue

*Howard Schaeffer

* Fred Coe, management style

* BW working atmosphere

* marketing within BW

* Wellbutrin

* Zovirax

* differences between BW in UK and USA, why UK was less successful than USA

* John Vane and Moncada

* lamontrigine and trimethoprim

* Pedro Cuatrecasas, inc management style

* Bill Sullivan, management style, relationship with Hitchings

* Peter Howsam

* flotation

* Ted Haigler

* Lil Beauchamp

* acyclovir, inc pricing

* AZT, Retrovir and pricing

* merger with Glaxo

* Glaxo's marketing function

* comments on the company post merger.

14 May 2001

audio tape and transcript Tape 24

This item needs to be accessed onsite using specialist equipment. Email collections@wellcomecollection.org to request an appointment.